LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $48,000 | +140.0% | 338 | +177.0% | 0.00% | +100.0% |
| Q3 2018 | $20,000 | -100.0% | 122 | -90.0% | 0.00% | -88.9% |
| Q2 2018 | $210,952,000 | +5273700.0% | 1,216 | +2795.2% | 0.02% | – |
| Q3 2017 | $4,000 | -20.0% | 42 | -37.3% | 0.00% | – |
| Q2 2017 | $5,000 | +66.7% | 67 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 67 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | – | 67 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |